A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of SP-8008 in Healthy Male Subjects
Latest Information Update: 02 Nov 2021
Price :
$35 *
At a glance
- Drugs SP-8008 (Primary)
- Indications Acute coronary syndromes; Stroke
- Focus Adverse reactions
- Sponsors Shin Poong Pharmaceutical
- 04 Mar 2021 New trial record